abrdn Life Sciences Investors
HQL
63 hedge funds and large institutions have $58.4M invested in abrdn Life Sciences Investors in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 7 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 14
12% more capital invested
Capital invested by funds: $52.3M → $58.4M (+$6.12M)
2.4% more ownership
Funds ownership: 14.61% → 17.01% (+2.4%)
3% less funds holding
Funds holding: 65 → 63 (-2)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cornerstone Advisors
Asheville,
North Carolina
|
+$2.47M |
| 2 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$2.36M |
| 3 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
+$1.27M |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$928K |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$720K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$749K |
| 2 |
HWAM
Hennion & Walsh Asset Management
Parsippany,
New Jersey
|
-$402K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$273K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$217K |
| 5 |
AUB
Atlantic Union Bankshares
Glen Allen,
Virginia
|
-$151K |
HQL Hedge Fund Activity: Q3 2022 in Review
63 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2022, worth a combined $58.4M — up 12% from $52.3M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of HQL and 6 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 30 added.
The largest buyer was Cornerstone Advisors, adding an estimated $2.47M. The largest seller was Advisors Asset Management, cutting an estimated $749K.
- 63 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2022, down from 65 in Q2 2022.
- Funds reported $58.4M of abrdn Life Sciences Investors stock for Q3 2022, up 12% quarter-over-quarter.
- 6 funds opened new abrdn Life Sciences Investors positions in Q3 2022 and 7 closed out, a net change of -1 holder.
- The largest abrdn Life Sciences Investors buyer in Q3 2022 was Cornerstone Advisors, an estimated $2.47M added.
- The largest abrdn Life Sciences Investors seller in Q3 2022 was Advisors Asset Management, an estimated $749K sold.
Based on aggregated 13F filings for Q3 2022.